SYNTHESIS AND DYNAMIC NMR STUDY OF NEW STABLE YLIDES
1115
C, 66.29; H, 5.52%. MS: m/z (%) = 618 (M+, 3), 615 (18), 557 (10), 433 (30), 294 (20),
278 (32), 277 (78), 262 (100), 239 (18), 220 (20), 201 (19), 183 (72), 152(20), 108 (26),
77 (27), 43 (54).
Dimethyl 2-(2,2-dimethyl-4,6-dioxo-5-propionyl-1,3-dioxane-5-yl)-3-(tri
phenyl-λ5-phosphanylidene) succinate (6c). IR (KBr) (υmax, cm−1): 1735 (C O),
1667, 1555 (C O), 1300, 1264, 1195, 1155 (C O). 1H NMR (300.1 MHz, CDCl3): δH =
1.24 (3 H, t, J 7.1 Hz, CH3), 1.67 (6 H, t, J = 7.2 Hz, 2 CH3), 1.74 (6 H, s, 2 CH3), 2.93 (2
H, q, J = 7.1 Hz, CH2), 6.81 (1 H, s, CH), 7.37–7.69 (15 H, m, 3 C6H5). 13C NMR (75.47
MHz, CDCl3): δC = 9.6 (CH2CH3), 26.8 (2 CH3), 28.1 (CH), 29.4 (2 CH2), 42.5 (d, 1JPC
=
=
1
127.95 Hz, P C), 52.1 (2 CH3), 91.6 (C(C O)3), 104.6 (C(CH3)2), 122.5 (d, JPC
3
4
99.00 Hz, Cipso), 128.2 (d, JPC 11.0 Hz, Cmeta), 130.9 (d, JPC 2.0 Hz, Cpara), 134.5 (d,
3
2
2JPC 10.0 Hz, Cortho), 165.1 (d, JPC 12.7 Hz, C O ester), 170.5 (d, JPC 13.6 Hz, C O
ester), 194.4 (C O). 31P NMR (121.49 MHz, CDCl3): δP = 29.4 ppm. Anal. calcd. for
C33H33O9P (604.589): C, 65.56; H, 5.50%. Found: C, 65.69; H, 5.42%. MS: m/z (%) =
604 (M+, 3), 530 (6), 443 (8), 420 (10), 347 (15), 293 (15), 278 (30), 277 (70), 262 (100),
201 (20), 183 (73), 152 (18), 108 (23), 77 (25), 57 (30), 43 (45).
Diethyl
2-(2,2-dimethyl-4,6-dioxo-5-propionyl-1,3-dioxane-5-yl)-3-(tri
phenyl-λ5-phosphanylidene) succinate (6d). IR (KBr) (υmax, cm−1): 1730, 1666,
1556 (C O), 1305, 1260, 1189, 1155 (C O). 1H NMR (300.1 MHz, CDCl3): δH = 1.28
3
3
(3H, t, JH,H = 7.15 Hz, CH3), 1.30 (6H, t, JH,H = 7.18 Hz, CH3), 1.74 (6H, s, 2 CH3),
2.93 (2 H, q, 3JH,H = 7.15 Hz, CH2), 4.20 (4 H, q, 3JH,H = 7.18 Hz, 2 CH2), 6.80 (1 H, s,
CH), 7.37–7.69 (15 H, m, 3 C6H5). 13C NMR (75.47 MHz, CDCl3): δC = 9.6 (CH2CH3),
26.7 (2 CH3), 26.8 (2 OCH2CH3), 29.0 (CH), 29.5 (CH2), 42.8 (d, 1JPC = 128.2 Hz, P C),
61.3 (2 CH2), 91.8 (C(C O)3), 104.8 (C(CH3)2), 122.9 (d, 1JPC = 99.24 Hz, Cipso), 127.3
3
4
2
(d, JPC 11.0 Hz, Cmeta), 130.5 (d, JPC 2.0 Hz, Cpara), 133.9 (d, JPC 10.0 Hz, Cortho),
3
2
164.8 (d, JPC 12.8 Hz, C O ester), 170.3 (d, JPC 13.8 Hz, C O ester), 194.5 (C O).
31P NMR (121.49 MHz, CDCl3): δP = 29.1 ppm. Anal. calcd. for C35H37O9P (632.642):
C, 66.45; H, 5.90%. Found: C, 66.29; H, 5.82%. MS: m/z (%) = 632 (M+, 6), 586 (5), 557
(8), 447 (22), 308 (11), 278 (30), 277 (71), 262 (100), 220 (6), 183 (61), 167 (15), 108
(20), 77 (25), 43 (44).
Dimethyl 2-(2,2-dimethyl-4,6-dioxo-5-(2-phenylacetyl)-1,3-dioxane-5-yl)-
3-(triphenyl-λ5-phosphanylidene) succinate (6e). IR (KBr), υ(cm−1): 1735, 1667,
1555 (C O), 1303, 1264, 1190, 1156 (C O). Anal. calcd. for C38H35O9P (666.659): C,
68.46; H, 5.29%. Found: C, 68.29; H, 5.12%. MS: m/z (%) = 590 (M+, 1), 515 (5), 429
(8), 405 (7), 368 (10), 332 (8), 293 (10), 278 (32), 277 (74), 262 (100), 236 (8), 201 (18),
183 (72), 152 (20), 108 (24), 77 (23), 57 (23), 43 (51).
Major: 1H NMR (300.1 MHz, CDCl3): δH = 1.40 (6H, s, 2CH3), 3.80 (3H, s, OCH3),
3.83 (3 H, s, OCH3), 5.28 (2 H, s, PhCH2), 6.20 (1H, d, JPH = 12.02 Hz, CH), 6.85–8.04
(20 H, m, 4 C6H5). 13C NMR (75.47 MHz, CDCl3): δC = 29.7 (C(CH3)2), 38.1 (PhCH2),
39.2 (d, 1JPC = 130.07 Hz, P C), 48.6, 52.1 (2 OCH3), 61.5 (C(C O)3), 104.1 (C(CH3)2),
117.4 (d, 1JPC = 99.02 Hz, Cipso), 125.1–137.7 (4 C6H5), 169.1 (d, 2JPC = 14.0 Hz, PCCO),
175.6, 209.3 (C O). 31P NMR (121.49 MHz, CDCl3): δP = 23.7 ppm.
Minor: 1H NMR (300.1 MHz, CDCl3): δH = 1.36 (6H, s, 2CH3), 3.37 (3H, s, OCH3),
3.78 (3H, s, OCH3), 4.95 (2 H, s, PhCH2), 5.92 (1 H, d, JPH 12.08 Hz, CH), 6.85–8.04
(20 H, m, 4 C6H5). 13C NMR (75.47 MHz, CDCl3): δC = 29.2 (C(CH3)2), 38.2 (PhCH2),
45.9 (d, 1JPC = 130.02 Hz, P C), 48.6, 57.2 (2 OCH3), 62.6 (C(C O)3), 104.3 (C(CH3)2),
120.4 (d, 1JPC = 99.02 Hz, Cipso), 125.1–137.7 (4 C6H5), 172.1 (d, 2JPC = 14.0 Hz, PCCO),
175.8 (C O), 210.3 (C O). 31P NMR (121.49 MHz, CDCl3): δP = 23.1 ppm.